Deals

British BioCell

Activity: Leading developer and manufacturer of raw materials and finished test platforms for the in-vitro diagnostics market.

Gambit Corporate Finance LLP acted as lead advisor to ceraint shareholders of British BioCell on its flotation on AIM by way of an IPO.

Sector

Healthcare & Medical

Transaction
Management Buy-out
MBO’s
Frank Holmes
Frank Holmes
Partner

Related deals advised by Gambit

Management Buy-out
Outsource UK
Management Buy-out
Just Love Food Company
Management Buy-out
ComputerWorld
Management Buy-out
Minerva Laboratories & Ultrawave
Management Buy-out
Accessory Bits (ABL)
Management Buy-out
Celtic Couriers
Acquisition, Management Buy-out
Pinnacle Complete Office Solutions
Management Buy-out
Pinnacle Telecom
View all

How can we help?

Get in touch with our team of experts to find out how we can support you and your business.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Gambit London
23 Berkeley Square, Mayfair, London, W1J 6HE
+44 (0)845 643 5500
info@gambitcf.com
Gambit Cardiff
3 Assembly Square, Britannia Quay, Cardiff, CF10 4PL
+44 (0)845 643 5500
info@gambitcf.com

© 2023 Gambit Corporate Finance LLP is authorised and regulated by the Financial Conduct Authority FRN 520662. The firm is not subject to the requirements of the Stewardship code. Registered Number: OC350202

Privacy Policy

Cookie Policy

Website design by Karolo

Twitter Linkedin

Search Gambit Corporate Finance

Twitter Linkedin